MMA Events · Mind Medicine Australia
Mind Medicine Australia logo
Donate

Doing More Harm than Good – Why current medicines are not working for the majority of patients

Join this free, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

Clinical trials assess the efficacy of psychiatric drugs over the short term. But what about their long-term effects? A comprehensive review of the scientific literature reveals that that psychiatric drugs, on the whole, increase the likelihood that a person will remain symptomatic and functionally impaired.

In this webinar Robert Whitaker (USA) will explain why current pharmacotherapy treatments for chronic mental illness fail over the longterm and the need for innovation to introduce new treatments to combat mental illness.

Learning points

Following the presentation there will be a Q & A panel with Tania de Jong AMRobert Whitaker (USA) and Peter Hunt AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

About medicinal psychedelic treatments

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Robert Whitaker (USA)

Robert Whitaker is a journalist who has specialized in covering medicine and science. His articles on psychiatry and the pharmaceutical industry have won a George Polk Award for Medical Writing, and a National Association of Science Writers’ Award for best magazine article. In 1998, he co-wrote a series on abuses in psychiatric research that was a finalist for the Pulitzer Prize in Public Service. He is the author of four books. His most recent one is Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Tripping to Enlightenment? Consciousness, Religion, Mental Health and Psychedelics

Join this free, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

The Mystery Religions of the ancient world frequently, if not always, employed the use of psychoactive drugs or entheogens to induce altered states of consciousness. Such experiences were indispensable to the initiation of members, their rituals relating to spiritual development, and ultimately the attainment of the “peak” experience(s) that represented the apotheosis and fulfillment of their theological and spiritual initiations.

All religions have been either directly or indirectly interested in human consciousness. Most religions expect that an awareness of the transcendent will cause a change of consciousness in the devotee. A mere sense that, ‘we are not alone’ or perhaps, ‘the context of our vast universe prevents any particular individual from believing they are the centre, around which all else moves’.

Sacred places, sacred rites and indeed all sacraments, exist to bring about a change of consciousness in the religious person. Baptism, marriage, ordination, last rites all seek to reorient a person to a change of circumstance, to bring a change of consciousness that will better equip a person for the change of circumstance.

In various religious traditions, communities have met mostly on a weekly basis to participate in rituals, that aim to be “food for the journey”. For example, the rite of communion is ingestion of wine and bread that becomes by virtue of the rite, an ingestion of grace, the very essence of the person of Jesus.

As the Western world become less religious, it’s hardly surprising that some of the ancient wisdom should be found in a more medical framework. Under the proper conditions and used intentionally, psychedelics are able to produce mystical, religious, or otherwise deeply meaningful experiences which can be employed for therapeutic purposes. These medicines help people to heal, process trauma, commune with others, or divine something about themselves and the universe. Psychedelics lend themselves to the concept of spiritual enlightenment at the most intimate personal levels. They also reveal collective truths, as well as scientific ones, to ‘change our minds’, our communities and our world.

Why shouldn’t a qualified therapist with medical training use certain medicines to bring about a change of consciousness in order to bring a change in circumstance and improve wellbeing? Neither religious practitioner or medical practitioner need to adopt the language of the other but each can concede a place for the other in the interest of bringing people to improved health and better circumstance.

Imagine if we could repair society by helping human beings feel connected to each other and to the universe!

Following the presentation there will be a Q & A panel with Tania de Jong AMPeter Hunt AMRabbi Zac KamenetzImam Tawhidi and Pastor Graham Long AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.More about medicinal psychedelic treatments.

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed. The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Rabbi Zac Kamenetz

M.A.

Rabbi Zac Kamenetz is the founder and CEO of Shefa, an education and advocacy organization dedicated to supporting individual and collective healing, self-discovery, and transformation by unlocking the practical wisdom of Jewish mystical traditions, sharing them as a guiding force. Shefa provides seekers with a Jewish framework for direct spiritual experience, prepares communities for the integration of psychedelics into mainstream therapeutic and religious culture, and empowers them to bring the wisdom, wellbeing, and joy that arise from direct perception of the divine into their daily lives. Zac received rabbinic ordination in 2012 an MA from the Graduate Theological Union/UC Berkeley. A sought-after speaker and educator, Zac lives in Berkeley, CA with his wife and their daughter.

Imam Tawhidi

Imam Mohammad Tawhidi is an Islamic scholar, educator, best-selling author, speaker, and one of the leading voices in the global movement of social Islamic reform. He has dedicated his life to ideologically tackling the spread of Islamic extremism and has delivered speeches at conferences, parliaments, mosques, Islamic centers, churches, synagogues, temples and universities across the Middle East, Europe, America, Asia, and Australia. He is licensed by Islamic leaders of the highest order to lead and represent the Muslim community. Tawhidi enjoys healthy international diplomatic relationships with numerous governments and provides regular advice on counter-terrorism. Imam Tawhidi was publicly ordained as an Islamic authority in the Holy City of Qum, Iran, by the Senior Grand Ayatollah Shirazi in 2010. He was recognized by the Senate of Canada on Wednesday June 13th of 2018, and is fluent in Arabic, English and Farsi.

Pastor Graham Long AM

At the time that Wayside called him into Ministry, Graham was a postie. He’d almost perfected riding a little motor bike when Wayside called him to be their next Minister. In his first life, Graham was a social worker in South Australia, specialising in the field of child protection. Graham trained for ministry from 1979 to 1982. After a few years in church ministry, Graham became a chaplain to Parramatta Prison and he ran a church welfare agency. Academically, after ordination, Graham pursued studies in philosophy achieving degrees from Catholic Theological Union and from the Catholic Institute of Sydney. A Masters honours in philosophy was halted when a near fatal motorcycle accident changed all of life’s priorities in 2001. Graham has been married to Robyn for 49 years and together they have two children and five grandchildren. Graham is the author of three books. Graham was named NSW Local Hero in the Australia Day awards of 2014 made a Member of the Order of Australia on the Queen’s Birthday 2015.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Busting psychedelic myths and exploring cross cultural taboos and nuances

Don’t miss out – Get your tickets early!

Join this free online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

In this webinar special guest speakers, Kyle Buller and Joe Moore from Psychedelics Today will share their experiences of breaking down the stigma and myths associated with psychedelic and cross-cultural psychedelic taboos and nuances. Dr. Alana Roy will share the current challenges and triumphs working in the field of psychedelic science in Australia and how you can help break down these barriers to ensure Australia has access to psychedelic medicine.

After this screening, a live “bust a myth/you can’t ask that” mental health panel Q and A discussion will occur with Dr. Alana Roy and Renee Harvey. Participants will have the opportunity to challenge assumptions, biases, and culturally constructed beliefs. Furthermore, participants will be given practical tools on how to become educated, ethical, and informed psychedelic advocates to help join the movement in Australia.

About medicinal psychedelic treatments

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Kyle Buller

M.S.

Kyle earned his B.A. in Transpersonal Psychology from Burlington College, where he focused on studying the healing potential of non-ordinary states of consciousness by exploring shamanism, Reiki, local medicinal plants and plant medicine, Holotropic and Dreamshadow Transpersonal Breathwork.

Kyle also earned his M.S. in Clinical Mental Health Counseling with an emphasis on Somatic Psychology. Kyle’s clinical background in mental health consists of working with at-risk teenagers in crisis and with individuals experiencing an early-episode of psychosis and providing counseling to undergraduate/graduate students in a university setting.

Joe Moore

Joe is a co-founder of Psychedelics Today. He is a long time student of psychedelics, psychology, and of the pioneering psychedelic psychiatrist, Dr. Stanislav Grof. After discovering the work of Dr. Stanislav Grof in 2001, Joe began studying psychedelics. In 2003 he started participating heavily in Holotropic Breathwork workshops. Joe spent time community organizing in Boston around permaculture, psychedelics, breathwork, shamanism and more. His biggest event in Boston was the “Ayahuasca Monologues” in 2011.

Dr Alana Roy

Ph. D Psychology, B. A Social Work (MHSW)

Dr Alana Roy is a psychologist, social worker and therapist and has spent the last 13 years working in mental health, suicide prevention, trauma, sexual abuse, family violence and the disability sector. Alana has worked with borderline personality and dissociative identity disorder in various roles in the community such as: Rape Crisis Centres with victims of ritual abuse, childhood and adult sexual assault, supporting women in the sex industry, survivors of human trafficking and now as a psychedelic integration specialist.

Alana focuses on harm reduction, community and connection. She is dedicated to psychedelic-assisted psychotherapy and plant medicines. She has engaged with, and provides integration therapeutic support services for communities across Australia. Alana works at several universities as a Research Fellow and supervisor of students on placement. Alana passionately advocates for public policy, community education and legislative changes so that these treatments are regulated and supported by a strong, connected and skilled sector.

Learn more about Alana’s experiences in: Psychedelic Medicines: How My Journey Into The Jungle Changed My Life

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

The psychology of addiction (Part 2)

Join this free, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

 

About medicinal psychedelic treatments

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Dr Eli Kotler

MBBS MPM FRANZCP Cert. Old Age Psych. AFRACMA

Eli is a consultant psychiatrist and psychodynamic psychotherapist. He is the Medical Director of Malvern Private Hospital, an addiction and trauma hospital in Melbourne. Eli completed the inaugural CPAT course, and has since been on its faculty. He was appointed as the course’s Australian Course Director in 2023.

As a psychiatric trainee, Eli was awarded the Royal College of Psychiatrists Trainee Prize for his Scholarly Project on Depression, as well as a Research Committee Trainee award for his work on Philosophy of Mind. As an adjunct lecturer at Monash University, he oversees medical students on their addiction medicine rotation, and sneaks in lectures on Philosophy of Mind, Psychodynamic Psychiatry and Psychedelic Assisted Therapies (PAT). He has been invited as a key-note speaker by the RANZCP and International Psychoanalytic Association to lecture on PAT. He has been invited by the Victorian Government to design new addiction programs and works with the AFL players association.

Eli is an Associate Fellow of the Royal Australasian College of Medical Administrators, and is a member of the Australasian Professional Society on Alcohol and other Drugs. He also has extensive research experience with novel therapeutics for neurodegenerative diseases. He sits on the Victorian Medical Panels, and is an expert witness in historical abuse cases.

Clinically, Eli works in a psychodynamic framework, and attempts to help his patients find freedom from their addictions and trauma through relational experiences, and experiential self-awareness. He is actively treating patients in Australia with MDMA-assisted therapy.

Dr Patrycja Slawuta (USA)

MA, PhD(c)MA

Patrycja Slawuta is an Australia-based, NYC-educated and Poland-born behavioural scientist, successful entrepreneur, and life-long learner.

After spending 10+ years in academia, Patrycja founded SelfHackathon, a NYC-based global boutique behavioural consultancy of scientists that applies evidence-based research to help organizations and enterprises navigate the complexities of human nature in the face of disruption, change and uncertainty.

After being chosen specifically by the Australian Government to migrate to Australia in March 2020 as a part of its Global Talent Program, Patrycja founded Unlab, a WA-based company whose mission is to take behavioural science out of the laboratory and into life through in-depth research initiatives, immersive learning programs and evidence-based consultations.

Patrycja believes the human mind is the world’s most untapped natural resource. As such, her mission is to give people and organizations clear frameworks and practical tools to meaningfully and efficiently mine their own minds in order to find purpose, clarity and alignment. In her free time she runs marathons (28 so far), reads (audiobooks) and meditates. In that particular order.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Adelaide Screening: Trip of Compassion: A window into psychedelic-assisted psychotherapy

Don’t miss out – Fundraiser Event – Adelaide’s FIRST screening of the world acclaimed film – Trip of Compassion.

By popular demand, Mind Medicine Australia is thrilled to welcome you to our premiere screening of Trip of Compassion, an acclaimed Israeli documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows a number of patients participating in clinical trials in Israel, and is the first feature documentary to show footage from within psychedelic-assisted therapies sessions.

Our previous viewings have sold out within days of being announced. Get your tickets early!

Tickets information

“I felt like I went through 15 years of psychological therapy in one night.”
–  Patient featured in Trip of Compassion

Following the screening there will be a Q&A panel and conversation. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

“Trip of Compassion is the most compelling movie I’ve seen in the last  year!”
– Tim Ferris, acclaimed author and podcaster

About medicinal MDMA

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer substantial advantage over current treatments. If forthcoming Phase 3 results confirm these treatments are effective, MDMA-assisted treatment of PTSD may become a prescription medicine as early as 2021 in some jurisdictions.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

By donating to Mind Medicine Australia, you will be helping us to accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support.

FREE WEBINAR: Endocannabinoid medicine; A gateway to psychedelic-assisted psychotherapy

Join this FREE, 60-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

The endocannabinoid system is essential for human homeostasis. An ancient signalling system ubiquitous in vertebrates. There is increasing evidence that ECS dysregulation results in numerous diseases as well inhibiting the bodies innate healing response. As we look to the future of psychedelic assisted therapy programmes endocannabinoid medicine will have a vital role to play in preparing people for the assisted psychotherapy process.

This session will explore:

What is the ECS?
How is the ECS involved in the development and treatment of PTSD / anxiety / depression?
How can we manipulate the ECS to improve assisted psychotherapy outcomes?

WEBINAR SESSION

Date: Wednesday 13 January 2021
Time: 7:25pm for 7:30pm start – 8:45pm (incl Q&A) (AEDT)
The presentation WILL BEGIN AT 7:30pm.
Location: Online. A link will be emailed to you with the viewing details once you have registered.

Following the presentation, there will be a Q & A panel with Dr Jamie Rickcord, Tania de Jong AM and Dr Alana Roy. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Trip of Compassion: A window into psychedelic-assisted therapies – Cairns

Don’t miss out – Fundraiser Event – Cairns’ FIRST screening of the world acclaimed film – Trip of Compassion.

Our previous viewings have sold out within days of being announced. Get your tickets early!

Mind Medicine Australia is thrilled to welcome you to Cairns’ premiere screening of Trip of Compassion, an acclaimed Israeli documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows a number of patients participating in clinical trials in Israel, and is the first feature documentary to show footage from within psychedelic-assisted therapies sessions.

“I felt like I went through 15 years of psychological therapy in one night.”
–  Patient featured in Trip of Compassion

You can watch the preview here:

Following the screening, there will be a Q & A panel. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

“Trip of Compassion is the most compelling movie I’ve seen in the last  year!”
– Tim Ferris, acclaimed author and podcaster

Director: Gil Karni,
Producers: Zafrir Kochanovsky & Miri Ezra – ttv Productions
Distributors: GO2FILMS

Date: Wednesday 20 January 2021

Time: 6:30pm for 7:00pm start –  9:15pm (incl Q&A Panel)

Location: Cairns Central Shopping Centre, Event Cinemas, Cnr Spence & McLeod Streets, Cairns

Ticket Price: $35 General Admission / $25 Concession

More about medicinal MDMA

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer substantial advantage over current treatments. If forthcoming Phase 3 results confirm these treatments are effective, MDMA-assisted treatment of PTSD may become a prescription medicine as early as 2021 in some jurisdictions.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Mind Medicine Australia FREE Webinar Series – A Radical New Somatic Approach to Psychedelic Psychotherapy

Don’t miss out – Get your tickets early!

Join this FREE, 60-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions.

The proposed presentation is on the psychobiological brain states that underpin the shift in consciousness induced by psychedelic substances. In particular, we cite the entropic brain model and the work of Robin Carhart-Harris who proposes dual modes of human consciousness that correspond to the presence and absence of default mode network activity. We tie this research to our clinical experience and discuss a new speculative model for psychedelic psychotherapy that targets homeostatic autonomic self correcting mechanisms that are potentiated by the psychedelic state. Our proposal is that psychedelic consciousness and the mammalian brain networks that underpin it give rise to a somatic processing pathway that is preferentially taken by psychedelic processes, and which has an autonomic, bottom-up capacity to address stress and PTSD symptoms more effectively than traditional top down cognitive, declarative forms of therapy. We further propose that a useful frontier in the psychedelic therapy movement involves developing psychotherapies that operate inside of the non-rational, non-linear, frequently non-verbal, and non-ordinary states of consciousness that are indicative of the psychedelic state.

Learning objectives:

To understand the neurological shifts in brain activity that is induced by psychedelic substances.

To understand the defense cascade threat response map & autonomic processing pathway that activates during psychedelic consciousness

To understand non-traditional somatic interventions designed to target innate psychobiological self correction

WEBINAR SESSION

Date: Wednesday 3 February 2021
Time: 12:55pm for 1:00pm start – 2:15pm (incl Q&A) (AEDT)

The presentation WILL BEGIN AT 1:00pm.

Location: Online. A link will be emailed to you with the viewing details.

Following the presentation there will be a Q & A panel with Saj Razvi (USA), Steven Elfrink (USA) and Tania de Jong AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Health Conversation: How Psychedelic Medicine can help Mental Health

Our mental health epidemic is increasing daily and further exacerbated by the pandemic. In the quest for new treatment options for mental illness and psychiatric disorders, attention is being paid to the potential role of microdoses of psychedelic drugs as adjuncts to psychotherapy for a wide array of maladies of the mind, including depression, anxiety, post-traumatic stress disorder and addictions.

With trials now also underway for dementia, OCD and eating disorders, this Health Conversation will examine the evidence for psychedelic-assisted therapies and investigate the potential applications of this novel therapy.

Join this panel to hear Tania de Jong AM, Peter Hunt AM, Dr Josephine Anderson and Rabbi Kamins discuss the potential future of psychedelic medicines.

Date: Sunday, 21 February, 2021

Time 10:30 AM – 12:00 PM

Location: online

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Josephine Anderson

Dr Josephine Anderson is a Conjoint Associate Professor at the UNSW and Clinical Director at the Royal Far West Centre for Country Kids, Manly. She also works as a consultant psychiatrist for the NSW Mental Health Review Tribunal, the Black Dog Institute and the Early Psychosis Program in South East Sydney Local Health District. Although Dr Anderson’s work is primarily clinical she has a keen interest in teaching and service development, with a focus on early intervention, innovative models of care and service integration, including those embracing partnerships with GPs and NGO care providers.

FREE WEBINAR: The Hungry Ghost: A Biopsychosocial Perspective on Addiction, from Heroin to Workaholism

Join this FREE, 60-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

For twelve years Dr. Maté was the staff physician at a clinic for drug-addicted people in
Vancouver’s Downtown Eastside, where he worked with patients challenged by hard-core drug
addiction, mental illness and HIV, including at Vancouver Supervised Injection Site. In his most
recent bestselling book In The Realm of Hungry Ghosts, he shows that their addictions do not
represent a discrete set of medical disorders; rather, they merely reflect the extreme end of a
continuum of addiction, mostly hidden, that runs throughout our society. In The Realm Of
Hungry Ghosts draws on cutting-edge science to illuminate where and how addictions originate
and what they have in common.

This session will explore:

Topics covered:
1. What is the source of addictions?
2. What happens chemically and physiologically in the brains of people with substance dependency or
behaviour addiction?
3. The false “blessings” of addiction as experienced by the addict (e.g., as emotional anaesthetic, as
personality booster, as social lubricant, and so on;)
4. The development of the addicted mind: how early childhood experiences shape the brain;
5. The social basis of addiction in economic, cultural and political dislocation and disempowerment;
6. How much choice does the addict really have, and how much responsibility?
7. Developing a therapeutic relationship in which healing is possible;
8.How to encourage the addict to take responsibility;
9. The prevention of addiction, both in adolescence and before.

WEBINAR SESSION

Date: Tuesday 23 February 2021
Time: 12:55pm for 1:00pm start – 2:15pm (incl Q&A) (AEDT)
The presentation WILL BEGIN AT 1:00pm.
Location: Online. A link will be emailed to you with the viewing details once you have registered.

Following the presentation, there will be a Q & A panel with Dr Gabor Maté  and Tania de Jong AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Dr Gabor Maté CM (Canada)

BA, MD, Doctor of Laws (honoris causa)

Gabor Maté (pronounced GAH-bor MAH-tay) is a retired physician who, after 20 years of family practice and palliative care experience, worked for over a decade in Vancouver’s Downtown East Side with patients challenged by drug addiction and mental illness. The bestselling author of five books published in nearly 40 languages, including the award-winning In the Realm of Hungry Ghosts: Close Encounters With Addiction, Gabor is an internationally renowned speaker highly sought after for his expertise on addiction, trauma, childhood development, and the relationship of stress and illness. For his ground-breaking medical work and writing he has been awarded the Order of Canada, his country’s highest civilian distinction, and the Civic Merit Award from his hometown, Vancouver. His most recent book, The Myth of Normal: Trauma, Illness and Healing in a Toxic Culture is a New York Times and international bestseller.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Fantastic Fungi Screening – Sydney

Don’t miss out – Get your tickets early! Previous session have sold out weeks in advance!

Mind Medicine Australia is thrilled to invite you to our screening of Fantastic Fungi on Monday the 1st of March 2021 at 6:30pm.

Don’t miss this film! Book your tickets today.

View the trailer here:

Mycelium is a life preserver, not only for our species, but for so many of the species that inhabit our Earth.

We’re asking you to start this revolution in the ecology of consciousness. Please help us. We can save this planet with your help and the help of Mycelium.

There are currently no medications that have proven effective in dealing with the massive increase in addiction, depression, trauma and suicide.

Psychedelic medicines are showing extraordinary results in clinical trials, and are on the fast track to becoming one of the most transformative tools of our time.

In a world where people feel so deeply disconnected, the use of medications to further detach them may work to dampen the emotions that are experienced, but often provide little relief and no profound insights into the internal experience of life. What science has shown is that psilocybin works to calm the region of the brain called the Default Mode Network and stimulates connections between new or under-utilised regions of the brain.

This stunning film by award-winning director Louie Schwartzberg touches on the ground-breaking work being done at Johns Hopkins, UCLA, New York University and other places. It will open a door to a meaningful and important conversation and exploration into the potential mushrooms offer.

The film also covers topics including innovation, health, wellness and medicine, the environment and biodiversity, foraging, food and cooking, consciousness and spirituality, culture, history and the arts.

How can you help? Watch the film! Bring along friends to watch the film together. Discuss the subject matter with others in your communities, and ask them to do the same.

Schwartzberg’s film quickly proves to be one of the year’s most mind-blowing, soul-cleansing and yes, immensely entertaining triumphs.

-Matt Fagerholm, RogerEbert.com

Date: Monday 1st of March 2021
Time: 6:00pm for 6:30pm start – 8:50pm (incl Q&A Panel) 
Location: Palace Chauvel Cinema, 249 Oxford St, Paddington NSW
Ticket Price: $30 Early Bird (ends February 12) / $35 General Admission / $25 Concession

Post Viewing Discussion Panel: 

Following the screening there will be a Q & A panel. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Director: Louis Schwartzberg
Producers: Elease Lui & Lyn Lear
Writer: Mark Monroe

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Trip of Compassion: A window into psychedelic-assisted therapies – Canberra

Don’t miss out – Canberra’s FIRST screening of the world acclaimed film – Trip of Compassion.

Our previous viewings have sold out within days of being announced. Be sure to grab your tickets early!

Mind Medicine Australia is thrilled to welcome you to Canberra’s’ premiere screening of Trip of Compassion, an acclaimed Israeli documentary on MDMA-assisted psychotherapy for the treatment of Post-Traumatic Stress Disorder (PTSD). Trip of Compassion follows a number of patients participating in clinical trials in Israel, and is the first feature documentary to show footage from within psychedelic-assisted therapies sessions.

I felt like I went through 15 years of psychological therapy in one night.
–  Patient featured in Trip of Compassion

You can watch the preview here:

Following the screening, there will be a Q & A panel with Tania de Jong AM, Peter Hunt AM and Admiral Chris Barrie AC. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Trip of Compassion is the most compelling movie I’ve seen in the last  year!
– Tim Ferris, acclaimed author and podcaster

Director: Gil Karni,
Producers: Zafrir Kochanovsky & Miri Ezra – ttv Productions
Distributors: GO2FILMS

DATE: Wednesday 3rd of March 2020 – 6:30pm

Location: Palace Electric Cinema, 2 Phillip Law Street, Canberra ACT,

The theatre will open at 6:00pm for 6:30pm start – 8:50pm (incl Q&A Panel)
Ticket Price: $30 EARLY BIRD (ends 19 February) / 35 General Admission / $25 Concession

More about medicinal MDMA

Psychedelic-assisted therapies offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

Results from Phase 2 clinical trials over the past decade have been so compelling that the Food and Drug Administration (FDA) in the United States recently designated MDMA-assisted psychotherapy as a ‘Breakthrough Therapy’. This designation highlights the FDA’s anticipation that these therapies may offer substantial advantage over current treatments. If forthcoming Phase 3 results confirm these treatments are effective, MDMA-assisted treatment of PTSD may become a prescription medicine as early as 2021 in some jurisdictions.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Admiral Chris Barrie AC​

MBA

Admiral Chris Barrie commanded all arms of the Defence Force as its Chief (CDF) from 1998 till 2002. After this, Chris worked on strategic leadership as a consultant, teacher and mentor, initially through Oxford University’s Strategic Leadership and Stimulus Forum Programs (2002-2011); and as Distinguished Visiting Professor he also taught an elective on Strategic Leadership to senior U.S. military officers at the National Defense University in Washington DC from 2004 till 2010.

He is busy now as the founder and Chair of Fearless- PTSD (Australia New Zealand), whose subsidiary ‘FearLess Outreach’ is intended to assist an estimated 6 million people in the Australian and New Zealand communities, who live with post-traumatic stress. He is an outspoken commentator on Climate Change and Security using community advocacy to raise awareness of the potential costs of inaction. Chris is also the Australian member of the Global Military Advisory Council on Climate Change (GMACCC), and an adjunct member of the Planetary Security Initiative based in the Hague.

FREE WEBINAR: Why med-tech firms, venture capitalists and bankers are investing in psychedelic medicine

Join this FREE, 60-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

Global interest and investment in psychedelic medicine companies is accelerating. However, these treatments are not like typical medicines. The patient experience and clinical care model is intense and also deeply, and necessarily, intertwined. So, the question arises, how can we develop care delivery models for these treatments that are safe, effective but also commercially viable? We will explore these themes with clinical service partner Emyria. We will explore how we are approaching these challenges and learn from Emryia’s experience creating an evidence-generating care model for medicinal cannabis.

This FREE webinar will explore:

  1. An overview of the psychedelic industry and its growth globally and locally
  2. The different types of for-profit commercial entities developing
  3. The need for these treatments in Australia and how we are actively preparing for their delivery
  4. Importance of working with a therapist the patient can trust and how set/setting play a role
  5. How the physical infrastructure of the clinic affects the patient experience. The importance of investing in the healing space
  6. The importance of co-creating robust and ethically-sourced clinical data with patients to ensure we learn from every patient

WEBINAR SESSION

Date: Wednesday 10 March 2021
Time: 7:25pm for 7:30pm start – 8:45pm (incl Q&A) (AEDT)
The presentation WILL BEGIN AT 7:30pm.
Location: Online. A link will be emailed to you with the viewing details once you have registered.

Following the presentation there will be a Q & A panel with Peter Hunt AM, Chairman and Co-founder of Mind Medicine Australia, Dr Michael Winlo, Managing Director of Emryia and Professor Alistair Vickery, Executive Medical Director of Emryia. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Dr Michael Winlo

Dr Michael Winlo, chief executive of Emerald Clinics since August 2019, was chief executive of Linear
Clinical Research for 3 years and remained on the board from July 2019 when he stepped down from the
CEO role to lead a startup company in digital health innovation. Linear Clinical Research is the clinical
trials arm of the Harry Perkins Institute of Medical Research. Dr Winlo holds a Bachelor of Medicine and
Surgery from the University of Western Australia, and an MBA from the Stanford Graduate School of
Business. He was a co-founder of medical device startup Cerulean Medical in 2007, and spent five years
in the US growing the health practice of data analysis firm Palantir Technologies

Prof Alistair Vickery

Alistair is the medical director of Emerald Clinics and has a wealth of expertise in clinical practice, health service management, clinical and educational research and board director skills.  He is adjunct Clinical Professor of Primary Health Care at the University of Western Australia and Notre Dame University and an active specialist general practitioner.  He is the clinical lead of the research group CHASM (The Collaborative for Health Care Analysis and Statistical Modelling) – providing high-level analysis and statistical modelling to inform WA Health clinical service planning and service evaluation. Alistair is Board Chair of Black Swan Health, one of the largest NFP primary health care, disability, and mental health services in Australia. Alistair is a Fellow of the Australasian College of Health Service Management and an AICD graduate.

Melbourne Chapter Opening Night

Don’t miss out – Mind Medicine Australia’s Melbourne Chapter Opening Night!

Please join us for this unique opportunity to network with your local community, meet industry experts, mental health advocates, passionate community members, philanthropists and official representatives at Mind Medicine Australia’s first event in Melbourne this year on March 17th from 6:00pm – 8:00pm.

Enjoy an engaging and informative presentation and Q&A from leading figures and experts from Mind Medicine Australia who are committed to the development of safe and effective psychedelic-assisted therapies to cure a range of mental illnesses.

This event will also include complimentary drinks and delicious canapés.

Mind Medicine Australia is Australia’s leading not-for-profit organisation working on the use of medicinal psilocybin and MDMA-assisted therapies to treat a range of mental illnesses. Mind Medicine Australia exists to help alleviate the suffering caused by our accelerating mental illness epidemic in Australia, through expanding the treatment options available to medical practitioners and their patients.

Unlike current treatments such as anti-depressants, which only manage the illness and can have undesirable side effects, psilocybin and MDMA assisted therapies have been scientifically proven to be a safe and effective cure for anxiety, depression, end-of-life stress, addictions and PTSD after just a short treatment program. These medicines are also currently being researched for dementia, eating disorders, OCD and a number of other conditions. Research from over 150 trials indicates that the medicines are safe and non-addictive when administered within a medically-controlled environment, and lead to remissions in 60-80% of patients after just 2-3 medicinal sessions in combination with psychotherapy.

Both medicines have been granted Breakthrough Therapy Status by the FDA in the USA to fast-track their approval. This designation is only given to medicines which may prove to be vastly superior to existing treatments.

At Mind Medicine Australia we are dedicated to helping the now global movement to spread this awareness and ensure these medicines are available via the medical system.

Watch this video to find out how and understand why Mind Medicine Australia is committed to bringing about this opportunity for those who need it the most;

Speaking on the night will be Tania de Jong AM, our Founder and Executive Director, Peter Hunt AM, Our Founder and Board Chair, Dr Alana Roy, Head of our Psychological Support Services and Melbourne Chapter Leaders Alvin Narsey and Brigid Blanckenberg.

Mind Medicine Australia (MMA) is a charity that seeks to alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We are focused on the development of safe and effective psychedelic-assisted therapies to cure a range of mental illnesses.

Many thanks to Mind Medicine Australia’s Melbourne Chapter for facilitating this event. Click here for more details or to join the Chapter!

Please support psychedelic research and therapy development by donating to Mind Medicine Australia. The recent pandemic has exacerbated Australia’s mental health epidemic and these treatments have the potential to cure millions of people who are suffering.

We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation.

Perth Chapter Opening Night

Don’t miss out – Mind Medicine Australia’s Perth Chapter Opening Night! 

Join local experts, mental health advocates, passionate community members, philanthropists and official representatives at Mind Medicine Australia’s first event in Perth on March 23rd from 6:00pm – 8:00pm.

The evening will feature a presentation and Q&A from leading figures and experts from Mind Medicine Australia and outline our plans going forward for the region.

We look forward to seeing you in person to usher in an exciting year for supporters of psychedelic-assisted medicine and therapies in Perth.

**Early Bird Tickets Available until the 10th of March**

Tickets include a light supper and a drink.

Mind Medicine Australia (MMA) is a charity that seeks to alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We are focused on the development of safe and effective psychedelic-assisted therapies to cure a range of mental illnesses.

Many thanks to Mind Medicine Australia’s Perth Chapter for facilitating this event. Click here for more details or to join the Chapter!

Please support psychedelic research and therapy development by donating to Mind Medicine Australia. The recent pandemic has exacerbated Australia’s mental health epidemic and these treatments have the potential to cure millions of people who are suffering.

We are a small organisation doing big things – we need your support.

Please click here to make a tax-deductible donation. 

FREE WEBINAR: Psilocybin versus SSRIs? A cure for depression

Join this FREE, 75-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

An interesting question is how psychedelics differ from conventional antidepressants that also work on the serotonin system. A trial has just completed at Imperial College comparing a 6-week SSRI escitalopram treatment versus two psilocybin therapy sessions for treatment of depression. Robin Carhart-Harris (UK) will report on the results of this exciting trial during this webinar and answer questions.

WEBINAR SESSION

Date: Wednesday 24 March 2021
Time: 7:55pm for 8:00pm start – 9:15pm (incl Q&A) (AEDT)
The presentation WILL BEGIN AT 8:00pm.
Location: Online. A link will be emailed to you with the viewing details once you have registered.

Following the presentation there will be a Q & A panel with Dr Robin Carhart-Harris and Tania de Jong AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Prof Robin Carhart-Harris (USA)

BSc, Ph.D

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has run and overseen brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and a current study comparing psilocybin with escitalopram for major depressive disorder. In 2019, he set-up the Centre for Psychedelic Research at Imperial and he also an honorary position with the University of Oxford. Two of his most influential works include the ‘Entropic Brain Hypothesis’ and ‘REBUS and the anarchic brain’.

Fantastic Fungi Screening – Byron Bay

Don’t miss out – Get your tickets early! Previous session have sold out weeks in advance!

Mind Medicine Australia is thrilled to invite you to our screening of Fantastic Fungi on Thursday the 25th of March 2021 at 6:30pm.

Don’t miss this film! Book your tickets today.

View the trailer here:

Mycelium is a life preserver, not only for our species, but for so many of the species that inhabit our Earth.

We’re asking you to start this revolution in the ecology of consciousness. Please help us. We can save this planet with your help and the help of Mycelium.

There are currently no medications that have proven effective in dealing with the massive increase in addiction, depression, trauma and suicide.

Psychedelic medicines are showing extraordinary results in clinical trials, and are on the fast track to becoming one of the most transformative tools of our time.

In a world where people feel so deeply disconnected, the use of medications to further detach them may work to dampen the emotions that are experienced, but often provide little relief and no profound insights into the internal experience of life. What science has shown is that psilocybin works to calm the region of the brain called the Default Mode Network and stimulates connections between new or under-utilised regions of the brain.

This stunning film by award-winning director Louie Schwartzberg touches on the ground-breaking work being done at Johns Hopkins, UCLA, New York University and other places. It will open a door to a meaningful and important conversation and exploration into the potential mushrooms offer.

The film also covers topics including innovation, health, wellness and medicine, the environment and biodiversity, foraging, food and cooking, consciousness and spirituality, culture, history and the arts.

How can you help? Watch the film! Bring along friends to watch the film together. Discuss the subject matter with others in your communities, and ask them to do the same.

Schwartzberg’s film quickly proves to be one of the year’s most mind-blowing, soul-cleansing and yes, immensely entertaining triumphs.

-Matt Fagerholm, RogerEbert.com

Date: Thursday 25th of March 2020
Time: 6:00pm for 6:30pm start – 8:45pm (incl Q&A Panel) 
Location: Byron Community Centre and Byron Theatre, 69 Jonson St, Byron Bay NSW 2481, Australia
Ticket Price: $30 Early Bird (ends March 5) / $35 General Admission / $25 Concession

Following the screening there will be a Q & A panel with Peter Hunt AM, Tania de Jong AM, Dr. Alana Roy and Dr. Jamie Rickcord. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Director: Louis Schwartzberg
Producers: Elease Lui & Lyn Lear
Writer: Mark Monroe

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Dr Alana Roy

Ph. D Psychology, B. A Social Work (MHSW)

Dr Alana Roy is a psychologist, social worker and therapist and has spent the last 13 years working in mental health, suicide prevention, trauma, sexual abuse, family violence and the disability sector. Alana has worked with borderline personality and dissociative identity disorder in various roles in the community such as: Rape Crisis Centres with victims of ritual abuse, childhood and adult sexual assault, supporting women in the sex industry, survivors of human trafficking and now as a psychedelic integration specialist.

Alana focuses on harm reduction, community and connection. She is dedicated to psychedelic-assisted psychotherapy and plant medicines. She has engaged with, and provides integration therapeutic support services for communities across Australia. Alana works at several universities as a Research Fellow and supervisor of students on placement. Alana passionately advocates for public policy, community education and legislative changes so that these treatments are regulated and supported by a strong, connected and skilled sector.

Learn more about Alana’s experiences in: Psychedelic Medicines: How My Journey Into The Jungle Changed My Life

Back By Popular Demand: Fantastic Fungi Second Exclusive Screening – Byron Bay

Don’t miss out – Get your tickets early! Previous session have sold out weeks in advance!

Mind Medicine Australia is thrilled to invite you to our second exclusive screening of Fantastic Fungi on Tuesday 30th of March 2021 at 6:30pm.

Don’t miss this film! Book your tickets today.

View the trailer here:

Mycelium is a life preserver, not only for our species, but for so many of the species that inhabit our Earth.

We’re asking you to start this revolution in the ecology of consciousness. Please help us. We can save this planet with your help and the help of Mycelium.

There are currently no medications that have proven effective in dealing with the massive increase in addiction, depression, trauma and suicide.

Psychedelic medicines are showing extraordinary results in clinical trials, and are on the fast track to becoming one of the most transformative tools of our time.

In a world where people feel so deeply disconnected, the use of medications to further detach them may work to dampen the emotions that are experienced, but often provide little relief and no profound insights into the internal experience of life. What science has shown is that psilocybin works to calm the region of the brain called the Default Mode Network and stimulates connections between new or under-utilised regions of the brain.

This stunning film by award-winning director Louie Schwartzberg touches on the ground-breaking work being done at Johns Hopkins, UCLA, New York University and other places. It will open a door to a meaningful and important conversation and exploration into the potential mushrooms offer.

The film also covers topics including innovation, health, wellness and medicine, the environment and biodiversity, foraging, food and cooking, consciousness and spirituality, culture, history and the arts.

How can you help? Watch the film! Bring along friends to watch the film together. Discuss the subject matter with others in your communities, and ask them to do the same.

Schwartzberg’s film quickly proves to be one of the year’s most mind-blowing, soul-cleansing and yes, immensely entertaining triumphs.

-Matt Fagerholm, RogerEbert.com

Date: Tuesday 30th of March 2021
Time: 6:00pm for 6:30pm start – 8:45pm (incl Q&A Panel) 
Location: Byron Community Centre and Byron Theatre, 69 Jonson St, Byron Bay NSW 2481, Australia
Ticket Price: $35 General Admission / $25 Concession

Following the screening there will be a Q & A panel with Peter Hunt AM, Tania de Jong AM, Dr. Alana Roy and Dr. Jamie Rickcord. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Director: Louis Schwartzberg
Producers: Elease Lui & Lyn Lear
Writer: Mark Monroe

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Peter Hunt AM

B.Com, LL.B

As an investment banker Peter Hunt AM advised local and multi-national companies and governments in Australia for nearly 35 years.  He co-founded one of Australia’s leading investment banking advisory firms, Caliburn Partnership and was Executive Chairman of Greenhill Australia. Peter was a member of the Advisory Panel of ASIC and chaired the Vincent Fairfax Family Office.

Peter is an active philanthropist involved in funding, developing and scaling social sector organisations which seek to create a better and fairer world.  He is Chairman of Mind Medicine Australia which he established with his wife, Tania de Jong, in 2018. He regularly presents to Governments, regulators, clinicians, philanthropists and the general public on psychedelic-assisted therapies and the legal and ethical frameworks needed to ensure these treatments can be made accessible and affordable. He was the lead author of Mind Medicine Australia’s successful rescheduling applications for MDMA and psilocybin, which made Australia the first country in the world to reschedule these medicines.

He founded Women’s Community Shelters in 2011. Peter is a Director of The Umbrella Foundation. Peter also acts as a pro bono adviser to Creativity Australia.  He was formerly Chairman of So They Can, Grameen Australia and Grameen Australia Philippines.

Peter was made a member of the General Division of the Order of Australia in the Queen’s Birthday Honours List in 2010 for services to the philanthropic sector.

Dr Alana Roy

Ph. D Psychology, B. A Social Work (MHSW)

Dr Alana Roy is a psychologist, social worker and therapist and has spent the last 13 years working in mental health, suicide prevention, trauma, sexual abuse, family violence and the disability sector. Alana has worked with borderline personality and dissociative identity disorder in various roles in the community such as: Rape Crisis Centres with victims of ritual abuse, childhood and adult sexual assault, supporting women in the sex industry, survivors of human trafficking and now as a psychedelic integration specialist.

Alana focuses on harm reduction, community and connection. She is dedicated to psychedelic-assisted psychotherapy and plant medicines. She has engaged with, and provides integration therapeutic support services for communities across Australia. Alana works at several universities as a Research Fellow and supervisor of students on placement. Alana passionately advocates for public policy, community education and legislative changes so that these treatments are regulated and supported by a strong, connected and skilled sector.

Learn more about Alana’s experiences in: Psychedelic Medicines: How My Journey Into The Jungle Changed My Life

FREE WEBINAR: Learn more about Asia Pacific’s First Certificate in Psychedelic-Assisted Therapies (CPAT)™ and our Psychological Support Services

Don’t miss out – Get your tickets early!

Join this free, 60-minute online webinar to gain access to insights and learn about ground breaking treatments to chronic mental health conditions.

In this webinar, Dr Nigel Denning and Dr Alana Roy will provide an overview of Mind Medicine Australia’s Certificate in Psychedelic-Assisted Therapies (CPAT) and Psychological Support Services. CPAT is Australia’s first training in psychedelic medicine work. It presents a model of psychotherapy that integrates emergent research and practice literature on brain science and psychedelics/empathogens and links this field with best practice in psychotherapy.

Nigel has developed the CPAT course in conjunction with his colleague Dr Tra-ill Dowie. Nigel is a long term student of and collaborator with Dr Stanislav Grof, one of the pioneers of medicine work and the founder, along with his late wife Christina Grof, of Holotropic Breathwork, an analogue process for medicine work.

This session will share some of the key features of the CPAT course. Nigel will also present a model of practice that provides support and psychoeducation about medicine work for patients, best practice in supporting medicine sessions and a model of integration and ethical treatment termination using a defined treatment term of no more than 20 weeks.

Dr Alana Roy will discuss Mind Medicine Australia’s Psychological Support Services which range from assessment, therapy, study groups, psychedelic integration groups, short courses, student placements, volunteer, and employment opportunities for allied and integrative health care practitioners.

She will share practical tips for preparation, self care and integration by drawing on the literature and from her personal lessons in the fields of social work, psychology and medicine work.

About medicinal psychedelic treatments

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Dr Alana Roy

Ph. D Psychology, B. A Social Work (MHSW)

Dr Alana Roy is a psychologist, social worker and therapist and has spent the last 13 years working in mental health, suicide prevention, trauma, sexual abuse, family violence and the disability sector. Alana has worked with borderline personality and dissociative identity disorder in various roles in the community such as: Rape Crisis Centres with victims of ritual abuse, childhood and adult sexual assault, supporting women in the sex industry, survivors of human trafficking and now as a psychedelic integration specialist.

Alana focuses on harm reduction, community and connection. She is dedicated to psychedelic-assisted psychotherapy and plant medicines. She has engaged with, and provides integration therapeutic support services for communities across Australia. Alana works at several universities as a Research Fellow and supervisor of students on placement. Alana passionately advocates for public policy, community education and legislative changes so that these treatments are regulated and supported by a strong, connected and skilled sector.

Learn more about Alana’s experiences in: Psychedelic Medicines: How My Journey Into The Jungle Changed My Life

Nigel Denning

MA, MPsych

Nigel Denning is a Counselling Psychologist with 30 years of experience in the mental health sector.  He is the Managing Director and co-founder of Integrative Psychology and the Mind Medicine Institute.

Nigel’s expertise covers developmental trauma, institutional abuse, family violence, attachment disorder, relationship therapy and advanced concentration meditation.  He works with individuals, couples, families, groups and organisations.  Nigel has been involved in therapy and court reporting on several hundred cases from the Royal Commission into Childhood Institutional Sexual Abuse.  Nigel is a former Family Violence Coordinator for Relationships Australia. He has conducted research at the University of Melbourne, Faculty of Medicine, under the supervision of Professor Kelsey Hegarty on male perpetrator typologies. For over 10 years Nigel facilitated group psychotherapy for male perpetrators of family violence.  Nigel is an expert in trauma.

Nigel has extensive experience with psychedelic work internationally.  He began working with altered states of consciousness 35 years ago when he was introduced to Holotropic Breathwork through the guidance of Alf and Muriel Foote.  Twenty-five years ago, Nigel began to work with Dr Stanislav Grof, one of the leading pioneers in the clinical application of psychedelics.  Nigel co-founded the world’s first Spiritual Emergency Centre based on Grof’s work, in partnership with Tav Sparks, Director of Grof Transpersonal Training in North Carolina.  He was also lucky to meet Dr Albert Hoffman at a workshop organised by Grof at HR Geiger’s Museum/Gallery in Gruyere Switzerland. Nigel has also trained with the Multidisciplinary Association of Psychedelic Studies (MAPS) and successfully completed their clinician qualification. Nigel is passionate about educating clinicians into the potential of non-ordinary state work when done ethically and skillfully.

FREE WEBINAR: Psilocybin-assisted Therapy for End-of-Life Distress

Join this FREE, 75-minute online webinar to gain access to insights and learn about groundbreaking treatments to chronic mental health conditions.

Renewed interest in the therapeutic effects of psychedelics such as psilocybin has driven a rich array of academic research over the past two decades. In 2016 researchers at New York University (NYU) and John Hopkins University co-published two landmark studies reporting on the effects of a single dose of psilocybin-assisted therapy for the treatment of anxiety and depression associated with a cancer diagnosis. In the NYU study, Agin-Liebes et al (2020) found that at the 4.5 year follow-up 60–80% of participants continued to meet criteria for clinically significant antidepressant or anxiolytic responses. Participants overwhelmingly (71–100%) attributed positive life changes to the psilocybin-assisted therapy experience and rated it among the most personally meaningful and spiritually significant experiences of their lives. These findings suggest that psilocybin-assisted psychotherapy can occasion spiritually salient experiences and holds promise in promoting long-term relief from cancer-related existential and psychiatric distress.

Dr. Gabby Agin-Liebes is a clinical psychologist and NIH-funded researcher at UC San Francisco. She was the lead investigator of the long-term follow-up study at NYU, which garnered media attention in several news outlets including Newsweek and CNN. In this presentation she will discuss:

WEBINAR SESSION:

Date: Wednesday 28 April 2021
Time: 11:55am for 12:00pm start – 1:15pm (incl Q&A) (AEST)
The presentation WILL BEGIN AT 12:00pm.
Location: Online. A link will be emailed to you with the viewing details once you have registered.

Following the presentation, there will be a Q & A panel with Dr Gabby Agin-Liebes and Tania de Jong AM. This will be an opportunity to engage in a discussion about psychedelic-assisted psychotherapies for mental illness broadly, and what Mind Medicine Australia and other local organisations are doing here in Australia.

Support these events:

Whilst our webinars are free of charge, we strongly encourage you to make a donation and support our important mission of making these therapies available through our medical system. This can be done at the time of reserving your ticket. Please share these events with your networks.

More about medicinal psychedelic treatments:

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

Dr Gabby Agin-Liebes (USA)

PH.D

Gabby Agin-Liebes, PhD is a clinical psychologist with 10 years of experience working as a therapist and investigator on academic trials with psilocybin-assisted therapy at New York University, Yale and UC San Francisco (UCSF). Her research has applied quantitative and qualitative methodologies within psilocybin-assisted and mindful self-compassion-based interventions to treat substance use and trauma-based disorders. She is currently a National Institutes of Health-funded research fellow at UCSF studying novel interventions for treating opioid addiction and chronic pain that target dysregulated emotion regulation and attentional bias processes. She is the lead author on a paper published earlier this year, and featured in several news outlets, which found that psilocybin-therapy led to sustained clinical remission from depression and anxiety in individuals with cancer up to 4.5 years later.

Tania de Jong AM

LL.B (Hons), GradDipMus

Tania de Jong AM is the co-Founder and Executive Director of Mind Medicine Australia. She regularly presents on psychedelic-assisted therapies, mental health and wellbeing at major conferences and events around the world and to Governments, regulators, clinicians, philanthropists and the general public.

Tania is one of Australia’s most successful female entrepreneurs and innovators developing 6 businesses and 4 charities including Creative Universe, Creativity Australia and With One Voice, Umbrella Foundation, Creative Innovation Global, Pot-Pourri and The Song Room.

Tania was named in the 100 Women of Influence, the 100 Australian Most Influential Entrepreneurs and named as one of the 100 most influential people in psychedelics globally in 2021. Tania’s TED Talk has sparked international interest. Tania has garnered an international reputation as a performer, speaker, entrepreneur and a passionate leader for social change. Her mission is to change the world, one voice at a time!

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×